[go: up one dir, main page]

PE20091176A1 - NEW CRYSTALLINE C FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID - Google Patents

NEW CRYSTALLINE C FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID

Info

Publication number
PE20091176A1
PE20091176A1 PE2008002132A PE2008002132A PE20091176A1 PE 20091176 A1 PE20091176 A1 PE 20091176A1 PE 2008002132 A PE2008002132 A PE 2008002132A PE 2008002132 A PE2008002132 A PE 2008002132A PE 20091176 A1 PE20091176 A1 PE 20091176A1
Authority
PE
Peru
Prior art keywords
fluoropropyl
amino
phosphinic acid
new crystalline
crystalline
Prior art date
Application number
PE2008002132A
Other languages
Spanish (es)
Inventor
Ida Hoyer
Roy A Moezzifard
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PE20091176A1 publication Critical patent/PE20091176A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO EN FORMA CRISTALINA C DE ACIDO (2R)-(3-AMINO-2-FLUOROPROPIL)FOSFINICO CARACTERIZADO POR UN PATRON DE RAYOS X EN POLVO QUE REPRESENTA SUSTANCIALMENTE d: 5,8 ANGSTROM. REFERIDA ADEMAS A UNA FORMULACION SIENDO UTIL EN EL TRATAMIENTO DEL ASMA RELACIONADO CON EL REFLUJO, ENFERMEDADES PULMONARES, SINDROME DE DECLIVE, TRASTORNOS GASTROINTESTINAL FUNCIONAL, ENTRE OTROSREFERS TO A COMPOUND IN CRYSTALLINE C FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID CHARACTERIZED BY A POWDERED X-RAY PATTERN THAT SUBSTANTIALLY REPRESENTS d: 5.8 ANGSTROM. ALSO REFERRED TO A FORMULATION BEING USEFUL IN THE TREATMENT OF ASTHMA RELATED TO REFLUX, PULMONARY DISEASES, DECLINE SYNDROME, FUNCTIONAL GASTROINTESTINAL DISORDERS, AMONG OTHERS

PE2008002132A 2007-12-21 2008-12-18 NEW CRYSTALLINE C FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID PE20091176A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1583307P 2007-12-21 2007-12-21

Publications (1)

Publication Number Publication Date
PE20091176A1 true PE20091176A1 (en) 2009-09-03

Family

ID=40801459

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008002132A PE20091176A1 (en) 2007-12-21 2008-12-18 NEW CRYSTALLINE C FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID

Country Status (5)

Country Link
AR (1) AR070046A1 (en)
PE (1) PE20091176A1 (en)
TW (1) TW200940560A (en)
UY (1) UY31555A1 (en)
WO (1) WO2009082348A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904508D0 (en) * 1999-12-09 1999-12-09 Astra Ab New compounds
SE0102057D0 (en) * 2001-06-08 2001-06-08 Astrazeneca Ab New Salts I
WO2009014490A1 (en) * 2007-07-25 2009-01-29 Astrazeneca Ab Combination of (3-amino-2-fluoropropyl)phosphinic acid and omeprazole for treating tlesr, gerd, and nerd

Also Published As

Publication number Publication date
UY31555A1 (en) 2009-08-03
AR070046A1 (en) 2010-03-10
TW200940560A (en) 2009-10-01
WO2009082348A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
ECSP088414A (en) DERIVATIVES OF BIFENYLLOXYACETIC ACID FOR THE TREATMENT OF A RESPIRATORY DISEASE
DOP2006000170A (en) NEW DERIVATIVES OF ESPIROCROMANONA
DOP2006000210A (en) AMIDA PYRIMIDINE COMPOUNDS AS PGDS INHIBITORS
JP2011518833A5 (en)
ATE465719T1 (en) ORAL DISSOLVING COMPOSITION OF OLNZAPINE OR DONEPEZIL
JP2014515038A5 (en)
BR112014003225A2 (en) vehicle-linked treprostinil prodrugs
JP2012107014A5 (en)
ECSP14013173A (en) 3,5-DIAMINO-6-CHLORINE-N- (N- (4- (4- (2- (HEXIL (2,3,4,5,6-PENTAHYDROXIHEXIL)) AMINO) ETOXI) PHENYL) BUTIL) CARBAMIMIDOIL) PIRAZINA -2-CARBOXAMIDE
DK2150530T3 (en) Substituted sulfonamide derivatives
CY1109369T1 (en) Substituted pyrrolopyridines, the compounds containing them, their manufacturing process and their use
PE20070828A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A GLYCOPYRONIUM SALT
AR124688A2 (en) A PYRIMIDINE SULFONAMIDE OR A TAUTOMER THEREOF, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
UY29223A1 (en) PHENOXYACETIC ACIDS REPLACED, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION
PE20141155A1 (en) ANALOGS OF EPOXY-EICOSATRIENOIC ACID AND METHODS FOR MAKING AND USING THE SAME
PE20121467A1 (en) AEROSOL FORMULATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
MX2010002407A (en) Co-crystals and pharmaceutical compositions comprising the same.
EA200802104A1 (en) APPLICATION OF COMPOSITIONS CONTAINING ANTAGONISTS OF CAPPA-OPIOID RECEPTORS FOR THE TREATMENT OF DISSOCIATIVE DISORDERS
JP2011515406A5 (en)
PE20091176A1 (en) NEW CRYSTALLINE C FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID
ATE533477T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IRBESARTAN
ECSP055821A (en) NEW PULVERULENT FORMULATION CONTAINING INHALATION TIOTROPY
PE20121132A1 (en) SOLID ORAL FORMULATIONS AND CRYSTAL FORMS OF A PROTEIN INHIBITOR OF APOPTOSIS
AR069649A1 (en) 4- (2,3- DIFLUORO-6- (2- FLUORO-4- METHYL- PHENYLSULPHANIL) - PHENYL) - PIPERIDINE
PE20090639A1 (en) POLYMORPHIC FORMS OF (S) -2 - ((4-BENZOFURANIL) CARBONYLAMINOMETHYL) -1 - ((4- (2-METHYL-5- (4-FLUOROPHENYL)) THIAZOLYL) CARBONYL) PIPERIDINE

Legal Events

Date Code Title Description
FD Application declared void or lapsed